Skip to content
CancerIndex

Publication

GLP-1 receptor agonists are associated with lower kidney cancer risk after metabolic bariatric surgery.

Jesús Gibran Hernández-Pérez, Omer Abdelgadir, Mohanad Albayyaa, Deepali K Ernest, Jing Chen, Stacia M DeSantis, Arthur S Hong, Lindsay G Cowell, Jaime P Almandoz, Sarah E Messiah, David S Lopez

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationAug 26, 2026PMID 42644757doi:10.1093/ndt/gfag197 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 18, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260918-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: Kidney cancer (KC) is an obesity-related malignancy with rising incidence. Although metabolic and bariatric surgery (MBS) reduces the risk of some obesity-related cancers, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) has increased after MBS; however, their association…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.